Arash Yavari

Arash Yavari is Chief Scientific Officer (CSO) of Imbria Pharmaceuticals and a physician scientist by training. Arash serves as a consultant to Imbria Pharmaceuticals and has supported the scientific and clinical development of the programs since 2019.

Arash also serves as Senior Drug Development Clinician with Weatherden, a London-based biotech-focused consulting organization, and is a University Research Lecturer and Principal Investigator at the Radcliffe Department of Medicine, University of Oxford. Arash holds a B.Sc. and M.B. B.S. from the University of London, a DPhil from the University of Oxford and is on the GMC Specialist Register. He is a Member of the Royal College of Physicians (MRCP) of the United Kingdom and Member of the Faculty of Pharmaceutical Medicine (MFPM).